Please check your internet connection and try again.
## Sompraz HP (Omeprazole)
### Overview
Sompraz HP is a brand name for omeprazole, a proton pump inhibitor (PPI) used to reduce stomach acid production. It is often used in combination therapy for the treatment of *Helicobacter pylori* infection.
### Primary Indications
* **Treatment of *Helicobacter pylori* infection:** In combination with antibiotics (e.g., amoxicillin and clarithromycin) for the eradication of *H. pylori* in patients with duodenal ulcers.
* **Healing of duodenal ulcers.**
* **Gastroesophageal reflux disease (GERD).**
* **Pathological hypersecretory conditions.**
### Adult Dosing
* **For *H. pylori* eradication:** Typically a triple therapy regimen including omeprazole 20 mg twice daily, amoxicillin 1000 mg twice daily, and clarithromycin 500 mg twice daily for 10-14 days. Some regimens may use omeprazole 40 mg once daily.
* **For duodenal ulcers:** 20 mg once daily for 4-8 weeks.
* **For GERD:** 20 mg once daily for 4-8 weeks.
* **For pathological hypersecretory conditions:** Starting dose is typically 60 mg once daily, titrated as needed. Doses may exceed 120 mg daily, administered in divided doses.
### Pediatric Dosing
Dosing in children is less well-established and should be guided by prescriber expertise and specific product labeling.
* **For *H. pylori* eradication (12 years and older):** Similar to adult dosing, typically 20 mg twice daily with appropriate antibiotics for 10-14 days.
* **For GERD (1-16 years):** Doses range from 10 mg to 20 mg once daily, depending on severity and response.
### Dose Adjustments
* **Hepatic Impairment:** Reduce the dose, typically by half, in patients with severe hepatic impairment.
### Contraindications
* Known hypersensitivity to omeprazole, substituted benzimidazoles, or any component of the formulation.
### Adverse Effects
Common: Headache, diarrhea, nausea, abdominal pain, vomiting, constipation, flatulence.
Serious: *Clostridium difficile*-associated diarrhea, bone fractures (hip, wrist, spine) with long-term use, vitamin B12 deficiency, hypomagnesemia, renal tubulointersitial nephritis, systemic lupus erythematosus.
### Key Drug Interactions
* **CYP2C19 substrates:** Omeprazole can inhibit CYP2C19, potentially increasing levels of drugs like clopidogrel (reduced antiplatelet effect), citalopram, escitalopram, and diazepam.
* **CYP3A4 substrates:** May affect the metabolism of drugs like warfarin and tacrolimus.
* **Ketoconazole, itraconazole, posaconazole:** Omeprazole can decrease absorption due to reduced gastric acidity.
* **Methotrexate:** PPIs may increase methotrexate levels.
* **Rilpivirine, nelfinavir:** Concomitant use is generally not recommended due to decreased plasma concentrations.
### Monitoring
* Monitor for signs and symptoms of *H. pylori* eradication (e.g., resolution of ulcers).
* Monitor for electrolyte imbalances (magnesium, potassium) with prolonged use.
* Monitor for signs of bone fracture risk in patients with risk factors and on long-term therapy.
* Monitor for signs of vitamin B12 deficiency with prolonged therapy.
### Clinical Pearls
* Administer capsules or tablets before meals, preferably in the morning.
* If using enteric-coated granules, they should be mixed with a small amount of liquid (e.g., water, milk, or juice) and taken immediately.
* Long-term use of PPIs has been associated with potential risks, including bone fractures, C. difficile infection, and vitamin B12 deficiency. Consider the lowest effective dose for the shortest duration needed.
***
**Disclaimer:** This information is intended for clinical use and does not replace professional medical judgment. Always consult the most current prescribing information and relevant guidelines before making clinical decisions.
